Accelr8 Shares More Than Double in February to Lead GWDN Index

Mar 02, 2011

NEW YORK (GenomeWeb News) – Shares Accelr8 more than doubled in the month of February, as the firm disclosed mid-month that its technology evaluation agreement with Novartis Vaccines and Diagnostics has been extended to June 30, 2011.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu